2016
DOI: 10.1016/j.clnesp.2016.03.012
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: respectively. OSA severity was evaluated through the apnea-hypopnea index (AHI), and the disease was characterized as severe if AHI values were 30 episodes/hour of sleep. Results: The 86.7% of the patients were obese, while 92.3%, 100% and 98.5% had elevated WC, WHR and WHtR, respectively. A statistically significant positive correlation was observed between AHI and BMI, WC, WHR and WHtR (rho¼0.28, 0.49, 0.49 and 0.37, respectively, all P<0.05). Patients with severe OSA had significantly higher WC and WHR comp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…Researchers from the same group are conducting a larger parallel, multi-centre study known as MEDINA (Mediterranean Dietary Intervention study in Non-Alcoholic fatty liver disease) [ 50 ], although published results are not available at this moment. On the other hand, a recent clinical trial including 28 overweight and obese patients with ultrasonography-proven NAFLD and abnormal liver enzymes who were randomly assigned to a MedDiet or a control diet for 6 months showed that ALT levels were significantly decreased only in the MedDiet group and that AST levels tended to decrease in the MedDiet group [ 44 ]. This improvement in liver function was accompanied by greater weight loss in the MedDiet group compared to that in the control subjects.…”
Section: Meddiet and Fatty Liver Managementmentioning
confidence: 99%
“…Researchers from the same group are conducting a larger parallel, multi-centre study known as MEDINA (Mediterranean Dietary Intervention study in Non-Alcoholic fatty liver disease) [ 50 ], although published results are not available at this moment. On the other hand, a recent clinical trial including 28 overweight and obese patients with ultrasonography-proven NAFLD and abnormal liver enzymes who were randomly assigned to a MedDiet or a control diet for 6 months showed that ALT levels were significantly decreased only in the MedDiet group and that AST levels tended to decrease in the MedDiet group [ 44 ]. This improvement in liver function was accompanied by greater weight loss in the MedDiet group compared to that in the control subjects.…”
Section: Meddiet and Fatty Liver Managementmentioning
confidence: 99%
“…The Acceptable Macronutrient Distribution Range (AMDR) for lipids is 20% to 35% of the daily diet in adults [ 18 ]. Trans and saturated fatty acids, as well as cholesterol, should be decreased to as low as possible and replaced with beneficial fat composition [ 19 ]. Polyunsaturated fatty acids (PUFAs), particularly Omega-3 fatty acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA), have many protective effects when studied in patients with NAFLD [ 20 ].…”
Section: Diet Typesmentioning
confidence: 99%
“…This diet is characterized as low-carbohydrate (40% of calories) and in contrast to low-fat diets, the Mediterranean diet includes fat as 40% of the diet, emphasizing the intake of MUFAs, olive oil, nuts, vegetables, fruits, fish, poultry, and legumes [ 31 , 45 , 46 , 47 ]. The diet replaces saturated and trans fatty acids with MUFAs and PUFAs [ 19 ]. The Mediterranean diet decreases the intake of processed meat, red meat, and leans towards a more plant-based diet [ 19 , 23 , 31 , 45 , 46 , 47 ].…”
Section: Diet Typesmentioning
confidence: 99%
See 2 more Smart Citations